Understanding the Treatment Choice Between Insulin Glargine, Detemir and Human Insulin: Characteristics of Patients with Type 2 Diabetes Starting Insulin in Five European Countries

Marloes Bazelier; Nils Ekstrom; Oystein Karlstad; Peter Vestergaard; Jari Haukka; Frank de Vries; Kari Furu; Morten Andersen; Marie De Bruin

Understanding the Treatment Choice Between Insulin Glargine, Detemir and Human Insulin: Characteristics of Patients with Type 2 Diabetes Starting Insulin in Five European Countries

Marloes Bazelier, Nils Ekstrom, Oystein Karlstad, Peter Vestergaard, Jari Haukka, Frank de Vries, Kari Furu, Morten Andersen, Marie De Bruin

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	124-124
Number of pages	1
Journal	Pharmacoepidemiology and Drug Safety
Volume	26
Publication status	Published - Aug 2017

Cite this

@article{fcfdcb1112e44627a25e49301f4095a1,

title = "Understanding the Treatment Choice Between Insulin Glargine, Detemir and Human Insulin: Characteristics of Patients with Type 2 Diabetes Starting Insulin in Five European Countries",

author = "Marloes Bazelier and Nils Ekstrom and Oystein Karlstad and Peter Vestergaard and Jari Haukka and {de Vries}, Frank and Kari Furu and Morten Andersen and {De Bruin}, Marie",

year = "2017",

month = aug,

language = "English",

volume = "26",

pages = "124--124",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley and Sons Ltd",

}

Understanding the Treatment Choice Between Insulin Glargine, Detemir and Human Insulin: Characteristics of Patients with Type 2 Diabetes Starting Insulin in Five European Countries. / Bazelier, Marloes; Ekstrom, Nils; Karlstad, Oystein et al.
In: Pharmacoepidemiology and Drug Safety, Vol. 26, 08.2017, p. 124-124.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Understanding the Treatment Choice Between Insulin Glargine, Detemir and Human Insulin: Characteristics of Patients with Type 2 Diabetes Starting Insulin in Five European Countries

AU - Bazelier, Marloes

AU - Ekstrom, Nils

AU - Karlstad, Oystein

AU - Vestergaard, Peter

AU - Haukka, Jari

AU - de Vries, Frank

AU - Furu, Kari

AU - Andersen, Morten

AU - De Bruin, Marie

PY - 2017/8

Y1 - 2017/8

M3 - Meeting Abstract

SN - 1053-8569

VL - 26

SP - 124

EP - 124

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

ER -